Calydon Capital

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1759271 MEMPHIS, TN

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$887,274

-$12,645 QoQ

Shares Held

1,987

+0.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100% Shared 0% None 0%

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$887,274	1,987	+0.1%	Shares	Sole	2026-05-15
2025-12-31	$899,919	1,985	-15.4%	Shares	Sole	2026-02-17
2025-09-30	$918,395	2,345	-39.4%	Shares	Sole	2025-11-14
2025-06-30	$1,723,369	3,871	+65.7%	Shares	Sole	2025-08-14
2025-03-31	$1,132,539	2,336	+3.5%	Shares	Sole	2025-05-15
2024-12-31	$909,296	2,258	-25.0%	Shares	Sole	2025-02-18
2024-09-30	$1,399,890	3,010	+26.4%	Shares	Sole	2024-11-13
2024-06-30	$1,116,022	2,381	-1.2%	Shares	Sole	2024-08-14
2024-03-31	$1,007,404	2,410	+7.9%	Shares	Sole	2024-05-15
2023-12-31	$908,585	2,233	-4.4%	Shares	Sole	2024-02-07
2023-09-30	$811,972	2,335	-4.8%	Shares	Sole	2023-11-01
2023-06-30	$862,883	2,452	-1.1%	Shares	Sole	2023-08-21
2023-03-31	$781,373	2,480	-28.2%	Shares	Sole	2023-05-11
2022-12-31	$997,446	3,454	-7.8%	Shares	Sole	2023-02-15
2022-09-30	$1,084,327	3,745	+4.3%	Shares	Sole	2022-11-14
2022-06-30	$1,012,189	3,592	-11.8%	Shares	Sole	2022-08-15
2022-03-31	$1,062,408	4,071	-7.9%	Shares	Sole	2022-05-05
2021-12-31	$971,071	4,422	+56.9%	Shares	Sole	2022-02-07
2021-09-30	$511,338	2,819	-34.2%	Shares	Sole	2021-11-10
2021-06-30	$863,379	4,282	-52.8%	Shares	Sole	2021-08-10
2021-03-31	$1,947,977	9,065	+104.4%	Shares	Sole	2021-05-13
2020-12-31	$1,047,931	4,434	+5.4%	Shares	Sole	2021-02-16
2020-09-30	$1,144,264	4,205	-3.4%	Shares	Sole	2020-11-12
2020-06-30	$1,264,300	4,355	+3.2%	Shares	Sole	2020-08-14
2020-03-31	$1,004,386	4,221	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.